These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7847448)

  • 21. Genetics of Mycobacterium tuberculosis and genotyping of drug resistance.
    Ortona L; Cingolani A
    Rays; 1998; 23(1):42-7. PubMed ID: 9673133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the horizontal gene exchange in evolution of pathogenic Mycobacteria.
    Reva O; Korotetskiy I; Ilin A
    BMC Evol Biol; 2015; 15 Suppl 1(Suppl 1):S2. PubMed ID: 25708825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular diagnosis, detection of drug resistance and epidemiology of tuberculosis.
    Drobniewski FA; Pozniak AL
    Br J Hosp Med; 1996 Sep 4-17; 56(5):204-8. PubMed ID: 8879698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mycobacterium tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells.
    Velmurugan K; Chen B; Miller JL; Azogue S; Gurses S; Hsu T; Glickman M; Jacobs WR; Porcelli SA; Briken V
    PLoS Pathog; 2007 Jul; 3(7):e110. PubMed ID: 17658950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular epidemiology of tuberculosis: achievements and challenges to current knowledge.
    Murray M; Nardell E
    Bull World Health Organ; 2002; 80(6):477-82. PubMed ID: 12132006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The LuxR family regulator Rv0195 modulates Mycobacterium tuberculosis dormancy and virulence.
    Fang H; Yu D; Hong Y; Zhou X; Li C; Sun B
    Tuberculosis (Edinb); 2013 Jul; 93(4):425-31. PubMed ID: 23673208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular genetics of drug resistance in Mycobacterium tuberculosis.
    Zhang Y; Young D
    J Antimicrob Chemother; 1994 Sep; 34(3):313-9. PubMed ID: 7829406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of fluoroquinolone resistance in Mycobacterium tuberculosis.
    Zhang YJ; Li XJ; Mi KX
    Yi Chuan; 2016 Oct; 38(10):918-927. PubMed ID: 27806933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs.
    Li Z; Kelley C; Collins F; Rouse D; Morris S
    J Infect Dis; 1998 Apr; 177(4):1030-5. PubMed ID: 9534978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolution of virulence in the Mycobacterium tuberculosis complex.
    Orgeur M; Brosch R
    Curr Opin Microbiol; 2018 Feb; 41():68-75. PubMed ID: 29216510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic principles of persistence and pathogenicity in Mycobacterium tuberculosis.
    Ehrt S; Schnappinger D; Rhee KY
    Nat Rev Microbiol; 2018 Aug; 16(8):496-507. PubMed ID: 29691481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholesterol oxidase is required for virulence of Mycobacterium tuberculosis.
    Brzostek A; Dziadek B; Rumijowska-Galewicz A; Pawelczyk J; Dziadek J
    FEMS Microbiol Lett; 2007 Oct; 275(1):106-12. PubMed ID: 17651430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of Tuberculosis Pathogenesis.
    Pepperell CS
    Annu Rev Microbiol; 2022 Sep; 76():661-680. PubMed ID: 35709500
    [No Abstract]   [Full Text] [Related]  

  • 34. Correlates between models of virulence for Mycobacterium tuberculosis among isolates of the Central Asian lineage: a case for lysozyme resistance testing?
    Pardieu C; Casali N; Clark SO; Hooper R; Williams A; Velji P; Gonzalo X; Drobniewski F
    Infect Immun; 2015 Jun; 83(6):2213-23. PubMed ID: 25776753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulsed field gel electrophoresis of representatives of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains.
    Varnerot A; Clément F; Gheorghiu M; Vincent-Lévy-Frébault V
    FEMS Microbiol Lett; 1992 Nov; 77(1-3):155-60. PubMed ID: 1459403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycobacterium tuberculosis ECF sigma factor sigC is required for lethality in mice and for the conditional expression of a defined gene set.
    Sun R; Converse PJ; Ko C; Tyagi S; Morrison NE; Bishai WR
    Mol Microbiol; 2004 Apr; 52(1):25-38. PubMed ID: 15049808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative analysis of microbial genomes to study unique and expanded gene families in Mycobacterium tuberculosis.
    Mulder N; Rabiu H; Jamieson G; Vuppu V
    Infect Genet Evol; 2009 May; 9(3):314-21. PubMed ID: 18243063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PhoP, a key player in Mycobacterium tuberculosis virulence.
    Ryndak M; Wang S; Smith I
    Trends Microbiol; 2008 Nov; 16(11):528-34. PubMed ID: 18835713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycobacterium tuberculosis evolutionary pathogenesis and its putative impact on drug development.
    Le Chevalier F; Cascioferro A; Majlessi L; Herrmann JL; Brosch R
    Future Microbiol; 2014; 9(8):969-85. PubMed ID: 25302954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virulence factors of the Mycobacterium tuberculosis complex.
    Forrellad MA; Klepp LI; Gioffré A; Sabio y García J; Morbidoni HR; de la Paz Santangelo M; Cataldi AA; Bigi F
    Virulence; 2013 Jan; 4(1):3-66. PubMed ID: 23076359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.